ipharmacenter

Find our #healthcare & #pharmaceutical #consulting services on #fiverr fiverr.com/ipharmacenter You can also write to info@ipharmacenter.com Our services include #Competitiveintelligence #Pipelinereports #Marketresearch #Marketaccess #Forecasting #news #media #pharma #freelance

#PresidentTrump signed the Most-Favored-Nation drug pricing executive order. This is the biggest shift in U.S. drug pricing in decades. Find the complete analysis now ipharmacenter.com/post/savings-f… #DrugPricing #MFN #Pharma #Healthcare #TrumpPolicy #BigPharma #Trump #TrumpPolicies

Find the complete blog here ipharmacenter.com/post/top-10-ph… #ECO2026 #ASCO2026 #drugdiscovery #innovation #pharma #pharmaceutical

Top #Pharma Companies 2025 youtu.be/vVb5LdQCsDU?si… #Pharma2025 #PharmaceuticalIndustry #EliLilly #NovoNordisk #HealthcareTrends #DrugDiscovery #Biotech #JohnsonAndJohnson #MedicalInnovation #MarketAnalysis #news #media #healthcare #innovation

At #ECO2026: #NovoNordisk: Oral #Wegovy - Early responders reached 21.6% by week 64 #Lilly: #Zepbound at max dose maintained full weight loss Find more details here ipharmacenter.com/post/european-… #pharma #Obesity #Healthcare #news #breaking #ObesityCare #innovation #weightloss

#FDA approves #Beqalzi (#sonrotoclax), first #BCL2 inhibitor for relapsed or refractory Mantle Cell #Lymphoma in the #UnitedStates Find more details here ipharmacenter.com/post/beone-med… #ASCO2026 #ASCO26 #OncoAlert #BloodMatters #pharma #Oncology #Healthcare #news #breaking #BeOne

#FDA grants second approval to #Sotyktu (#deucravacitinib), now approved for adults with active #PsoriaticArthritis First #TYK2 inhibitor approved for PsA in the #UnitedStates Find more details here ipharmacenter.com/post/fda-grant… #pharma #Healthcare #news #breaking #Rheumatology #Trump

Follow our #Telegram channel for real-time #pharma news: t.me/ipharma_center #news #media #breaking #pharma #pharmaceutical #healthcare #GlobalHealth #TrumpPolicies #MFN #marketaccess

Top 10 #US #healthcare companies by Q1'26 revenue #UnitedHealthGroup: $111.7B #CVSHealth: $100.4B #Cigna Group:$68.5B Full top‑10 ranking & segment breakdowns on iPharmaCenter ipharmacenter.com/post/top-10-u-… #Breaking #news #media #TrumpPolicies #Trump #marketaccess #health #globalhealth

Follow our #Telegram channel for real-time #pharma news: t.me/ipharma_center #news #media #breaking #pharma #pharmaceutical #healthcare #GlobalHealth #TrumpPolicies #MFN #marketaccess #ECO2026 #ObesityCare

#FDA approves #Foundayo (#orforglipron) — a #GLP1 tablet for weight loss by #Lilly Find more details here ipharmacenter.com/post/foundayo-… #pharma #Obesity #Healthcare #news #breaking #WeightLoss #ObesityCare #ECO2026

Follow our #Telegram channel for real-time #pharma news: t.me/ipharma_center #news #media #breaking #pharma #pharmaceutical #healthcare #GlobalHealth #breaking #TrumpPolicies #MFN #marketaccess

#MaxHealthcare (#Delhi), #Jaslok (#Mumbai), #Apollo (#Bengaluru), #Yashoda (#Hyderabad) and 29+ centers will anchor #AstraZeneca’s new K+ Connect network for hyperkalemia management in HF and CKD ipharmacenter.com/post/astrazene… #India #Bharat #pharma #pharmaceutical #healthcare

Follow our #Telegram channel for real-time #pharma news: t.me/ipharma_center #news #media #breaking #pharma #pharmaceutical #healthcare #GlobalHealth #breaking #TrumpPolicies #MFN

At #ECO2026: #NovoNordisk: Oral #Wegovy efficacy - Early responders reached 21.6% by week 64 #Lilly: #Zepbound at max dose maintained full weight loss Find more details here ipharmacenter.com/post/european-… #pharma #Obesity #Healthcare #news #breaking

Follow our #Telegram channel for real-time #pharma news: t.me/ipharma_center

Top 10 #Pharma Companies by #Revenue in 2026 (Q1 Official Figures) 1️⃣ J&J – $24.0B 2️⃣ Eli Lilly – $19.8B 3️⃣ Roche – $18.8B 4️⃣ AstraZeneca – $15.3B 5️⃣ Novo Nordisk – $15.2B Find more details here ipharmacenter.com/post/top-10-ph… #pharma #pharmaceutical #news #media #Healthcare #breaking

#NICE recommends #Spinraza & #Evrysdi for routine #NHS use in #SMA; #Imfinzi for aggressive stomach #cancer ipharmacenter.com/post/nice-reco… #marketaccess #pharma #pharmaceutical #rarediseases #ASCO2026 #innovation #news #media #UKNews #Healthcare #breaking #England

Most-Favored Nation drug pricing could deliver big savings for #US payers, but may also reshape global #pharma revenues and #access. Our latest analysis breaks down who wins, who loses, and why it matters ipharmacenter.com/post/savings-f… #news #media #Trump #PresidentTrump #healthcare

#AstraZeneca launches the K+ Connect program across #India to strengthen #hyperkalemia management in #heartfailure and #CKD, linking 33 tertiary centers in a multidisciplinary network. ipharmacenter.com/post/astrazene… #news #media #PMModi #Healthcare #Bharat #breaking

#NovoNordisk at #ECO2026: In the phase 3 OASIS 4 trial of oral #semaglutide 25 mg, 28.8% of adults were “early responders” (≥10% weight loss by week 16), reaching 21.6% weight loss by week 64 ipharmacenter.com/post/european-… #ECO26 #ObesityCare #news #media #innovation #weightloss